» Articles » PMID: 9284823

The Cell-cell Adhesion Receptor Mel-CAM Acts As a Tumor Suppressor in Breast Carcinoma

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1997 Sep 1
PMID 9284823
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Mel-CAM (MUC18 or CD146) is a cell adhesion molecule sharing sequence homology with members of the immunoglobulin gene superfamily. Mel-CAM was originally described as a marker associated with invasion and metastasis in melanoma. We determined here the distribution and biological significance of Mel-CAM in normal, benign proliferative, and neoplastic breast ductal epithelium. Using a Mel-CAM-specific monoclonal antibody, we, immunohistochemically demonstrate Mel-CAM expression in 14 of 14 (100%) normal breast epithelia and benign proliferative ductal epithelial lesions, whereas Mel-CAM expression can only be focally detected in 12 of 72 (17%) breast carcinomas. Solid-phase cell adhesion assay revealed that breast carcinoma cells in culture express the ligand for Mel-CAM. Transfection of Mel-CAM cDNA into breast carcinoma cells induces a more cohesive cell growth pattern and establishes smaller tumors in immunocompromised mice than mock transfectants. In conclusion, Mel-CAM is distributed throughout normal and benign proliferative mammary ductal epithelium, but it is frequently lost in carcinomas; it functions as a heterophilic cell-cell adhesion molecule in breast epithelium, and loss of Mel-CAM expression in breast carcinoma may be an important step for tumor progression.

Citing Articles

Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation.

Balcioglu O, Gates B, Freeman D, Hagos B, Mehrabad E, Ayala-Talavera D NPJ Breast Cancer. 2024; 10(1):80.

PMID: 39277578 PMC: 11401886. DOI: 10.1038/s41523-024-00687-7.


Single-cell and spatial analyses reveal a tradeoff between murine mammary proliferation and lineage programs associated with endocrine cues.

Gray G, Girnius N, Kuiken H, Henstridge A, Brugge J Cell Rep. 2023; 42(10):113293.

PMID: 37858468 PMC: 10840493. DOI: 10.1016/j.celrep.2023.113293.


Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.

Mannion A, Odell A, Baker S, Matthews L, Jones P, Cook G Front Cell Dev Biol. 2023; 11:1129015.

PMID: 37138793 PMC: 10150653. DOI: 10.3389/fcell.2023.1129015.


Soluble CD146 as a Potential Target for Preventing Triple Negative Breast Cancer MDA-MB-231 Cell Growth and Dissemination.

Sharma A, Joshkon A, Ladjimi A, Traboulsi W, Bachelier R, Robert S Int J Mol Sci. 2022; 23(2).

PMID: 35055160 PMC: 8780963. DOI: 10.3390/ijms23020974.


Role of Biomarkers in the Integrated Management of Melanoma.

Naik P Dis Markers. 2022; 2021:6238317.

PMID: 35003391 PMC: 8739586. DOI: 10.1155/2021/6238317.


References
1.
Burns F, von Kannen S, Guy L, Raper J, Kamholz J, Chang S . DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron. 1991; 7(2):209-20. DOI: 10.1016/0896-6273(91)90259-3. View

2.
Shih I, Wang T, Westra W . Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res. 1996; 2(3):569-75. View

3.
Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland K . Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron. 1991; 7(4):535-45. DOI: 10.1016/0896-6273(91)90366-8. View

4.
Pourquie O, Corbel C, Le Caer J, Rossier J, Le Douarin N . BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci U S A. 1992; 89(12):5261-5. PMC: 49271. DOI: 10.1073/pnas.89.12.5261. View

5.
Prasad G, Valverius E, McDuffie E, Cooper H . Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 1992; 3(8):507-13. View